Aslan Fred
Chief Executive Officer at ARTV
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Nov 17, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARTVArtiva Biotherapeutics, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARTVRoutineAug 15 2025
Sold 25,500 shares at $2.73 ($70k)
Aslan Fred, President and CEO
10b5-1 planSold 6.2% of holdings ($1.1M position)386,693 shares leftFirst sale on recordFiling
- 2 Form 4 sale ARTVRoutineOct 17 +63 days
Sold 25,500 shares at $6.00 ($153k)
Aslan Fred, President and CEO
10b5-1 planSold 6.7% of holdings ($2.3M position)356,721 shares leftFiling
- 3 Form 4 sale ARTVRoutineNov 17 +31 days
Sold 6,375 shares at $3.38 ($22k)
Aslan Fred, President and CEO
10b5-1 planSold 1.8% of holdings ($1.2M position)343,999 shares leftFiling
- 4 Form 4 sale ARTVRoutineDec 15 +28 days
Sold 3,187 shares at $6.00 ($19k)
Aslan Fred, President and CEO
10b5-1 planSold 0.3% of holdings ($7.3M position)1.2M shares left0.1x usual sizeFiling
- 5 Form 4 sale ARTVNo planMay 19 +155 days
Sold 27,116 shares at $9.01 ($244k)
Aslan Fred, Chief Executive Officer
No 10b5-1 planSold 1.7% of holdings ($14.1M position)1.5M shares left1.7x usual sizeFiling
- 6 Form 4 sale ARTVNo planSep 3 +107 days
Sold 61,888 shares at $11.16 ($691k)
Aslan Fred, Chief Executive Officer
No 10b5-1 planSold 4% of holdings ($17.1M position)1.5M shares left2.4x usual sizeFiling
- 7 Form 4 sale ARTVRoutineSep 8 +5 days
Sold 23,429 shares at $10.92 ($256k)
Aslan Fred, Chief Executive Officer
10b5-1 planSold 1.6% of holdings ($16.1M position)1.4M shares left0.9x usual sizeFiling
- 8 Form 4 sale ARTVUnusualNov 17 +70 days
Sold 119,771 shares at $3.91 ($469k)
Aslan Fred, Chief Executive Officer
No 10b5-1 planSold 8.2% of holdings ($5.7M position)1.3M shares left4.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | ARTV | Chief Executive Officer | Form 4 sale | 119,771 | $469k | 8.2% | Unusual | SEC |
| Sep 8, 2026 | ARTV | Chief Executive Officer | Form 4 sale | 23,429 | $256k | 1.6% | Routine | SEC |
| Sep 3, 2026 | ARTV | Chief Executive Officer | Form 4 sale | 61,888 | $691k | 4.0% | No plan | SEC |
| May 19, 2026 | ARTV | Chief Executive Officer | Form 4 sale | 27,116 | $244k | 1.7% | No plan | SEC |
| Dec 15, 2025 | ARTV | President and CEO | Form 4 sale | 3,187 | $19k | 0.3% | Routine | SEC |
| Nov 17, 2025 | ARTV | President and CEO | Form 4 sale | 6,375 | $22k | 1.8% | Routine | SEC |
| Oct 17, 2025 | ARTV | President and CEO | Form 4 sale | 25,500 | $153k | 6.7% | Routine | SEC |
| Aug 15, 2025 | ARTV | President and CEO | Form 4 sale | 25,500 | $70k | 6.2% | Routine | SEC |